Jiangsu Hengrui Medicine
600276.SS
#526
Rank
ยฃ31.66 B
Marketcap
ยฃ4.96
Share price
0.02%
Change (1 day)
13.78%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.07328. In 2022 the company made an earnings per share (EPS) of ยฃ0.07307 a decrease over its 2021 EPS that were of ยฃ0.08814.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.075463.26%
2022ยฃ0.07307-17.1%
2021ยฃ0.08814-24.44%
2020ยฃ0.1220.3%
2019ยฃ0.0969625.58%
2018ยฃ0.0772127.55%
2017ยฃ0.0605421.64%
2016ยฃ0.0497713.57%
2015ยฃ0.0438239.86%
2014ยฃ0.0313321.33%
2013ยฃ0.0258217.7%
2012ยฃ0.0219425.56%
2011ยฃ0.0174726.22%
2010ยฃ0.0138410.3%
2009ยฃ0.0125557.92%
2008ยฃ0.00794811.06%
2007ยฃ0.00715685.81%
2006ยฃ0.00385187.94%
2005ยฃ0.00204933.97%
2004ยฃ0.00152929.78%
2003ยฃ0.00117919.78%
2002ยฃ0.0009839